{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T11:07:49Z","timestamp":1795172869247,"version":"4.10.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The 2019 novel respiratory virus (SARS-CoV-2) causes COVID-19 with rapid global socioeconomic disruptions and disease burden to healthcare. The COVID-19 and previous emerging virus outbreaks highlight the urgent need for broad-spectrum antivirals. Here, we show that a defensin-like peptide P9R exhibited potent antiviral activity against pH-dependent viruses that require endosomal acidification for virus infection, including the enveloped pandemic A(H1N1)pdm09 virus, avian influenza A(H7N9) virus, coronaviruses (SARS-CoV-2, MERS-CoV and SARS-CoV), and the non-enveloped rhinovirus. P9R can significantly protect mice from lethal challenge by A(H1N1)pdm09 virus and shows low possibility to cause drug-resistant virus. Mechanistic studies indicate that the antiviral activity of P9R depends on the direct binding to viruses and the inhibition of virus-host endosomal acidification, which provides a proof of concept that virus-binding alkaline peptides can broadly inhibit pH-dependent viruses. These results suggest that the dual-functional virus- and host-targeting P9R can be a promising candidate for combating pH-dependent respiratory viruses.<\/jats:p>","DOI":"10.1038\/s41467-020-17986-9","type":"journal-article","created":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T06:04:04Z","timestamp":1598335444000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":103,"title":["A broad-spectrum virus- and host-targeting peptide against respiratory viruses including influenza virus and SARS-CoV-2"],"prefix":"10.1038","volume":"11","author":[{"given":"Hanjun","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin K. W.","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong-Hung","family":"Sze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy Tin-Mong","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjie","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoiyan","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man Lung","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2083-1552","authenticated-orcid":false,"given":"Kwok-Yung","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,25]]},"reference":[{"key":"17986_CR1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(04)15729-2","volume":"363","author":"PC Woo","year":"2004","unstructured":"Woo, P. C. et al. Relative rates of non-pneumonic SARS coronavirus infection and SARS coronavirus pneumonia. Lancet 363, 841\u2013845 (2004).","journal-title":"Lancet"},{"key":"17986_CR2","doi-asserted-by":"crossref","first-page":"14040","DOI":"10.1073\/pnas.0506735102","volume":"102","author":"SK Lau","year":"2005","unstructured":"Lau, S. K. et al. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl Acad. Sci. USA 102, 14040\u201314045 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17986_CR3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.00102-14","volume":"28","author":"JF Chan","year":"2015","unstructured":"Chan, J. F. et al. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin. Microbiol. Rev. 28, 465\u2013522 (2015).","journal-title":"Clin. Microbiol. Rev."},{"key":"17986_CR4","doi-asserted-by":"crossref","first-page":"16004","DOI":"10.1038\/nmicrobiol.2016.4","volume":"1","author":"ML Yeung","year":"2016","unstructured":"Yeung, M. L. et al. MERS coronavirus induces apoptosis in kidney and lung by upregulating Smad7 and FGF2. Nat. Microbiol 1, 16004 (2016).","journal-title":"Nat. Microbiol"},{"key":"17986_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","volume":"395","author":"JF Chan","year":"2020","unstructured":"Chan, J. F. et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet 395, 514\u2013523 (2020).","journal-title":"Lancet"},{"key":"17986_CR6","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(13)70167-1","volume":"13","author":"KK To","year":"2013","unstructured":"To, K. K., Chan, J. F., Chen, H., Li, L. & Yuen, K. Y. The emergence of influenza A H7N9 in human beings 16 years after influenza A H5N1: a tale of two cities. Lancet Infect. Dis. 13, 809\u2013821 (2013).","journal-title":"Lancet Infect. Dis."},{"key":"17986_CR7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1128\/CMR.05012-11","volume":"25","author":"VC Cheng","year":"2012","unstructured":"Cheng, V. C., To, K. K., Tse, H., Hung, I. F. & Yuen, K. Y. Two years after pandemic influenza A\/2009\/H1N1: what have we learned? Clin. Microbiol. Rev. 25, 223\u2013263 (2012).","journal-title":"Clin. Microbiol. Rev."},{"key":"17986_CR8","unstructured":"Li, Q. et al. Early transmission dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 382, 1199\u20131207 (2020)."},{"key":"17986_CR9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrmicro3475","volume":"13","author":"F Vigant","year":"2015","unstructured":"Vigant, F., Santos, N. C. & Lee, B. Broad-spectrum antivirals against viral fusion. Nat. Rev. Microbiol. 13, 426\u2013437 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"17986_CR10","volume":"10","author":"S Yuan","year":"2019","unstructured":"Yuan, S. et al. SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target. Nat. Commun. 10, 120 (2019).","journal-title":"Nat. Commun."},{"key":"17986_CR11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2897","volume":"9","author":"L Rajendran","year":"2010","unstructured":"Rajendran, L., Knolker, H. J. & Simons, K. Subcellular targeting strategies for drug design and delivery. Nat. Rev. Drug Discov. 9, 29\u201342 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"17986_CR12","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/ni.2229","volume":"13","author":"N Yan","year":"2012","unstructured":"Yan, N. & Chen, Z. J. Intrinsic antiviral immunity. Nat. Immunol. 13, 214\u2013222 (2012).","journal-title":"Nat. Immunol."},{"key":"17986_CR13","volume":"6","author":"H Zhao","year":"2016","unstructured":"Zhao, H. et al. A novel peptide with potent and broad-spectrum antiviral activities against multiple respiratory viruses. Sci. Rep. 6, 22008 (2016).","journal-title":"Sci. Rep."},{"key":"17986_CR14","volume":"9","author":"H Zhao","year":"2018","unstructured":"Zhao, H. et al. Dual-functional peptide with defective interfering genes effectively protects mice against avian and seasonal influenza. Nat. Commun. 9, 2358 (2018).","journal-title":"Nat. Commun."},{"key":"17986_CR15","volume":"8","author":"Y Yu","year":"2017","unstructured":"Yu, Y. et al. A peptide-based viral inactivator inhibits Zika virus infection in pregnant mice and fetuses. Nat. Commun. 8, 15672 (2017).","journal-title":"Nat. Commun."},{"key":"17986_CR16","volume":"5","author":"L Lu","year":"2014","unstructured":"Lu, L. et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat. Commun. 5, 3067 (2014).","journal-title":"Nat. Commun."},{"key":"17986_CR17","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.cell.2015.09.056","volume":"163","author":"MD Swanson","year":"2015","unstructured":"Swanson, M. D. et al. Engineering a therapeutic lectin by uncoupling mitogenicity from antiviral activity. Cell 163, 746\u2013758 (2015).","journal-title":"Cell"},{"key":"17986_CR18","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/ni1248","volume":"6","author":"E Leikina","year":"2005","unstructured":"Leikina, E. et al. Carbohydrate-binding molecules inhibit viral fusion and entry by crosslinking membrane glycoproteins. Nat. Immunol. 6, 995\u20131001 (2005).","journal-title":"Nat. Immunol."},{"key":"17986_CR19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.peptides.2013.07.014","volume":"48","author":"CJ Sample","year":"2013","unstructured":"Sample, C. J. et al. A mastoparan-derived peptide has broad-spectrum antiviral activity against enveloped viruses. Peptides 48, 96\u2013105 (2013).","journal-title":"Peptides"},{"key":"17986_CR20","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.peptides.2011.05.015","volume":"32","author":"Q Li","year":"2011","unstructured":"Li, Q. et al. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses. Peptides 32, 1518\u20131525 (2011).","journal-title":"Peptides"},{"key":"17986_CR21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1074\/jbc.RA118.005015","volume":"294","author":"F Li","year":"2019","unstructured":"Li, F. et al. A scorpion venom peptide Ev37 restricts viral late entry by alkalizing acidic organelles. J. Biol. Chem. 294, 182\u2013194 (2019).","journal-title":"J. Biol. Chem."},{"key":"17986_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.chom.2007.12.001","volume":"3","author":"JG Smith","year":"2008","unstructured":"Smith, J. G. & Nemerow, G. R. Mechanism of adenovirus neutralization by Human alpha-defensins. Cell Host Microbe 3, 11\u201319 (2008).","journal-title":"Cell Host Microbe"},{"key":"17986_CR23","doi-asserted-by":"crossref","unstructured":"Brice, D. C. & Diamond, G. Antiviral activities of human host defense peptides. Curr. Med. Chem. 27, 1420\u20131443 (2019).","DOI":"10.2174\/0929867326666190805151654"},{"key":"17986_CR24","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nri1860","volume":"6","author":"ME Klotman","year":"2006","unstructured":"Klotman, M. E. & Chang, T. L. Defensins in innate antiviral immunity. Nat. Rev. Immunol. 6, 447\u2013456 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"17986_CR25","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1074\/jbc.M411141200","volume":"280","author":"S Liu","year":"2005","unstructured":"Liu, S. et al. Different from the HIV fusion inhibitor C34, the anti-HIV drug Fuzeon (T-20) inhibits HIV-1 entry by targeting multiple sites in gp41 and gp120. J. Biol. Chem. 280, 11259\u201311273 (2005).","journal-title":"J. Biol. Chem."},{"key":"17986_CR26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.biotechadv.2018.01.004","volume":"36","author":"B Gomes","year":"2018","unstructured":"Gomes, B. et al. Designing improved active peptides for therapeutic approaches against infectious diseases. Biotechnol. Adv. 36, 415\u2013429 (2018).","journal-title":"Biotechnol. Adv."},{"key":"17986_CR27","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1038\/emboj.2011.286","volume":"30","author":"J Huotari","year":"2011","unstructured":"Huotari, J. & Helenius, A. Endosome maturation. EMBO J. 30, 3481\u20133500 (2011).","journal-title":"EMBO J."},{"key":"17986_CR28","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1172\/JCI25669","volume":"115","author":"A Moscona","year":"2005","unstructured":"Moscona, A. Entry of parainfluenza virus into cells as a target for interrupting childhood respiratory disease. J. Clin. Invest 115, 1688\u20131698 (2005).","journal-title":"J. Clin. Invest"},{"key":"17986_CR29","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa1716197","volume":"379","author":"FG Hayden","year":"2018","unstructured":"Hayden, F. G. et al. Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents. N. Engl. J. Med. 379, 913\u2013923 (2018).","journal-title":"N. Engl. J. Med."},{"key":"17986_CR30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2017.11.017","volume":"149","author":"YW Tan","year":"2018","unstructured":"Tan, Y. W., Yam, W. K., Sun, J. & Chu, J. J. H. An evaluation of chloroquine as a broad-acting antiviral against hand, foot and mouth disease. Antivir. Res. 149, 143\u2013149 (2018).","journal-title":"Antivir. Res."},{"key":"17986_CR31","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ebiom.2017.09.034","volume":"24","author":"C Li","year":"2017","unstructured":"Li, C. et al. Chloroquine, a FDA-approved drug, prevents Zika Virus infection and its associated congenital microcephaly in mice. EBioMedicine 24, 189\u2013194 (2017).","journal-title":"EBioMedicine"},{"key":"17986_CR32","doi-asserted-by":"crossref","unstructured":"Wang, M. et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. 30, 269\u2013271 (2020).","DOI":"10.1038\/s41422-020-0282-0"},{"key":"17986_CR33","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41421-020-0156-0","volume":"6","author":"J Liu","year":"2020","unstructured":"Liu, J. et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 6, 16 (2020).","journal-title":"Cell Discov."},{"key":"17986_CR34","doi-asserted-by":"crossref","first-page":"e1002976","DOI":"10.1371\/journal.ppat.1002976","volume":"8","author":"A Jurgeit","year":"2012","unstructured":"Jurgeit, A. et al. Niclosamide is a proton carrier and targets acidic endosomes with broad antiviral effects. PLoS Pathog. 8, e1002976 (2012).","journal-title":"PLoS Pathog."},{"key":"17986_CR35","doi-asserted-by":"crossref","first-page":"e0006715","DOI":"10.1371\/journal.pntd.0006715","volume":"12","author":"JC Kao","year":"2018","unstructured":"Kao, J. C. et al. The antiparasitic drug niclosamide inhibits dengue virus infection by interfering with endosomal acidification independent of mTOR. PLoS Negl. Trop. Dis. 12, e0006715 (2018).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"17986_CR36","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.3201\/eid2106.150176","volume":"21","author":"D Falzarano","year":"2015","unstructured":"Falzarano, D. et al. Lack of protection against ebola virus from chloroquine in mice and hamsters. Emerg. Infect. Dis. 21, 1065\u20131067 (2015).","journal-title":"Emerg. Infect. Dis."},{"key":"17986_CR37","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1473-3099(11)70065-2","volume":"11","author":"NI Paton","year":"2011","unstructured":"Paton, N. I. et al. Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial. Lancet Infect. Dis. 11, 677\u2013683 (2011).","journal-title":"Lancet Infect. Dis."},{"key":"17986_CR38","doi-asserted-by":"crossref","first-page":"e0136969","DOI":"10.1371\/journal.pone.0136969","volume":"10","author":"J Seppala","year":"2015","unstructured":"Seppala, J. et al. Flexible structure of peptide-bound filamin A mechanosensor domain pair 20\u201321. PLoS ONE 10, e0136969 (2015).","journal-title":"PLoS ONE"},{"key":"17986_CR39","volume":"5","author":"S Nakano","year":"2015","unstructured":"Nakano, S. et al. Structural and computational analysis of peptide recognition mechanism of class-C type penicillin binding protein, alkaline D-peptidase from Bacillus cereus DF4-B. Sci. Rep. 5, 13836 (2015).","journal-title":"Sci. Rep."},{"key":"17986_CR40","doi-asserted-by":"crossref","first-page":"21041","DOI":"10.1074\/jbc.271.35.21041","volume":"271","author":"PK Hammen","year":"1996","unstructured":"Hammen, P. K., Waltner, M., Hahnemann, B., Heard, T. S. & Weiner, H. The role of positive charges and structural segments in the presequence of rat liver aldehyde dehydrogenase in import into mitochondria. J. Biol. Chem. 271, 21041\u201321048 (1996).","journal-title":"J. Biol. Chem."},{"key":"17986_CR41","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2672.2010.04663.x","volume":"109","author":"B Michen","year":"2010","unstructured":"Michen, B. & Graule, T. Isoelectric points of viruses. J. Appl. Microbiol. 109, 388\u2013397 (2010).","journal-title":"J. Appl. Microbiol."},{"key":"17986_CR42","doi-asserted-by":"crossref","first-page":"6052","DOI":"10.1021\/bi900154f","volume":"48","author":"KB Chandrababu","year":"2009","unstructured":"Chandrababu, K. B., Ho, B. & Yang, D. Structure, dynamics, and activity of an all-cysteine mutated human beta defensin-3 peptide analogue. Biochemistry 48, 6052\u20136061 (2009).","journal-title":"Biochemistry"},{"key":"17986_CR43","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/cbic.200700560","volume":"9","author":"S Liu","year":"2008","unstructured":"Liu, S. et al. Linear analogues of human beta-defensin 3: concepts for design of antimicrobial peptides with reduced cytotoxicity to mammalian cells. Chembiochem 9, 964\u2013973 (2008).","journal-title":"Chembiochem"},{"key":"17986_CR44","unstructured":"To, K. K. et al. Consistent detection of 2019 novel coronavirus in saliva. Clin. Infect. Dis. 71, 841\u2013843 (2020)."},{"key":"17986_CR45","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jcv.2016.02.014","volume":"77","author":"KK To","year":"2016","unstructured":"To, K. K. et al. Pulmonary and extrapulmonary complications of human rhinovirus infection in critically ill patients. J. Clin. Virol. 77, 85\u201391 (2016).","journal-title":"J. Clin. Virol."},{"key":"17986_CR46","doi-asserted-by":"crossref","first-page":"8091","DOI":"10.1073\/pnas.0711942105","volume":"105","author":"BJ Zheng","year":"2008","unstructured":"Zheng, B. J. et al. Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A\/H5N1 virus. Proc. Natl Acad. Sci. USA 105, 8091\u20138096 (2008).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"17986_CR47","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2017.03.018","volume":"46","author":"DJ Holthausen","year":"2017","unstructured":"Holthausen, D. J. et al. An amphibian host defense peptide is virucidal for Human H1 hemagglutinin-bearing influenza viruses. Immunity 46, 587\u2013595 (2017).","journal-title":"Immunity"},{"key":"17986_CR48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10858-016-0060-y","volume":"66","author":"SP Skinner","year":"2016","unstructured":"Skinner, S. P. et al. CcpNmr AnalysisAssign: a flexible platform for integrated NMR analysis. J. Biomol. NMR 66, 111\u2013124 (2016).","journal-title":"J. Biomol. NMR"},{"key":"17986_CR49","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jmr.2009.11.008","volume":"202","author":"MS Cheung","year":"2010","unstructured":"Cheung, M. S., Maguire, M. L., Stevens, T. J. & Broadhurst, R. W. DANGLE: a Bayesian inferential method for predicting protein backbone dihedral angles and secondary structure. J. Magn. Reson. 202, 223\u2013233 (2010).","journal-title":"J. Magn. Reson."},{"key":"17986_CR50","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/bioinformatics\/btl589","volume":"23","author":"W Rieping","year":"2007","unstructured":"Rieping, W. et al. ARIA2: automated NOE assignment and data integration in NMR structure calculation. Bioinformatics 23, 381\u2013382 (2007).","journal-title":"Bioinformatics"},{"key":"17986_CR51","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00228148","volume":"8","author":"RA Laskowski","year":"1996","unstructured":"Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R. & Thornton, J. M. AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J. Biomol. NMR 8, 477\u2013486 (1996).","journal-title":"J. Biomol. NMR"},{"key":"17986_CR52","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera\u2013a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17986-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17986-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17986-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T19:27:20Z","timestamp":1670268440000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-17986-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,25]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["17986"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-17986-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.738565652.793579555","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-18687\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,25]]},"assertion":[{"value":"9 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4252"}}